2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92547°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
ÇÙ½É ¸®´õ ¿µÀÔ¡¦ Çö´ë¿ÀÅä¿¡¹ö, º¸¾È¡¤SW °æÀï·Â °­È­ ¼Óµµ (2024-07-05)
µ¹ºñ ½Ã³×¸¶, ¹«´õÀ§ ³¯¸± ¾×¼Ç °¡µæÇÑ 7¿ù °³ºÀÀÛ ¼Ò°³ (2024-07-05)
New Data and Recent Approval in China Cements Galderma¡¯s Le... (2024-11-15)
'½Å¶û¼ö¾÷¡¯ °³±×¿ì¸Õ°ú °áÈ¥Çϸé ÁÁ¾Æ... ¡®¹ÌÈ¥¹Ý¡¯ À§ÇØ ¹¶ÃÆ... (2024-08-28)
Çѱ¹Ã»¼Ò³âÄÚÄ¡Çùȸ 8¿ù 1ÀÏ ¹ßÁ· (2022-07-23)
±³Á÷¿ø°øÁ¦È¸, »ç¶ûÀÇ »§ ³ª´® ºÀ»çȰµ¿ (2024-08-03)
AppOmni and Cisco Partner to Extend SaaS Security with End-t... (2024-11-17)
Huons Speeds up Biopharmaceutical Development with Human-Der... (2024-11-17)
ĵ½ºÅæ, VX201 Áø°ø°ü ºí·çÅõ½º »ç¿îµå¹Ù ½ºÇÇÄ¿ (2023-10-19)
´©¸²ÅëÀå °¡ÀÔÀÚ ¹× º¸È£ÀÚ ´ë»ó ±ÝÀ¶±³À° ÁøÇà (2024-07-09)
ÇϳªÀºÇà, ÅðÁ÷¿¬±Ý ¡®¿ù Áö±Þ½Ä ä±ÇÇü ÆÝµå¡¯ Ãâ½Ã (2023-09-24)
KOTRA, Àü½Ãȸ Âü°¡±â¾÷¿¡ ¹°·ù ÈļÓÁö¿ø ³ª¼±´Ù (2023-08-11)
»ç¶ûÀÇ¿­¸Å, ¡®Èû³»¶ó! ´ëÇѹα¹ ³ª´®Ä·ÆäÀΡ¯ ½ÃÀÛ (2020-05-04)
µÎ¹ÙÀÌ, 2023³â ¹®È­ ¹× âÀÇ »ê¾÷ ºÐ¾ß FDI Àü ¼¼°è 1À§ (2024-06-20)
Ã¥ Àд »ï±«¾ß¿Üµµ¼­°ü, »õ·Î¿î µµ¼­°üÀÇ °¡´É¼º Á¦½Ã (2024-05-01)
üÄÚ¸ÆÁÖ ÄÚÁ©, ¡®ÄÚÁ© º¯¿ÂÀÜ ÆÐŰÁö¡¯ Ãâ½Ã (2024-02-14)
½Ä¿ë°ß¿¡ »õ·Î¿î À̸§ ¼±¹°ÇÏ´Â ¡®#NameMe¡¯ Ä·ÆäÀÎ (2019-06-20)
À̺êÀÚ¸®, 2024³â ÇϹݱ⠽ÅÁ¦Ç° ǰÆò ¼öÁÖȸ (2024-06-22)
¿¡±×µå¶ø, µþ±âÀÇ ¸À°ú »ö°¨ »ì¸° ½Å¸Þ´º 4Á¾ Ãâ½Ã (2024-04-06)
New McAfee Global Small Business Study Reveals Concerns, Kno... (2024-01-22)
¹«Àε¿·ÂºñÇàÀåÄ¡(µå·Ð) Á¤±âÀÎÁõ ÆÐ½ºÆ®Æ®·¢ µµÀÔ (2023-09-19)
¡®³ª´Â SOLO¡¯ 21±â ¿µÈ£, ¿Á¼ø¿¡ µÚ´ÊÀº Á÷Áø? (2024-07-23)
ÇÑÈ­, ¿µ±¹¿¡¼­ Çѱ¹ Ç×°ø¡¤¿ìÁÖ ¿ª·® ¼±º¸Àδ٠(2024-07-23)
´ëÇÐ ³» À½ÁÖ ¹®È­ °³¼± ¡®ÀÎÁ¤ÆÈÂ Ä·ÆäÀÎ (2018-03-11)
±Û·Î¹ú ¿¹¼úƯº°½Ã ¼­¿ï·Î µµ¾à... ¹®È­¿¹¼ú ±â¹Ý°ú Á¤Ã¥ ¼±µµ (2024-01-30)
       [ÀÌÀü][1]....[595][596][597][598][599][600][601][602][603]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..